Gut microbiome signature of Viliuisk encephalomyelitis in Yakuts includes an increase in microbes linked to lean body mass and eating behaviour
- PMID: 33218345
- PMCID: PMC7678198
- DOI: 10.1186/s13023-020-01612-4
Gut microbiome signature of Viliuisk encephalomyelitis in Yakuts includes an increase in microbes linked to lean body mass and eating behaviour
Abstract
Background: Viliuisk encephalomyelitis (VE) is a rare endemic neurodegenerative disease occurring in the Yakut population of Northeastern Siberia. The main clinical features of VE are spasticity, dysarthria, dementia, central paresis and paralysis, and cortical atrophy observed via MRI. Many hypotheses have been proposed regarding its etiology, including infectious agents, genetics, environmental factors, and immunopathology. Each of these hypotheses has been supported to some extent by epidemiological and experimental data. Nevertheless, none of them has been decisively proven. Gut microbiome is one of the factors that might be involved in VE pathogenesis.
Results: Here we performed a pilot survey of the stool microbiomes of Yakut subjects with VE (n = 6) and without VE (n = 11). 16S rRNA sequencing showed that in comparison with the control group, the Yakuts with VE had increased proportions of Methanobrevibacter and Christensenella, which are reported to be linked to body mass index, metabolism, dietary habits and potentially to neurodegenerative disorders. The identified associations suggest that the microbiome may be involved in VE. Overall, the Yakut microbiome was quite specific in comparison with other populations, such as metropolitan Russians and native inhabitants of the Canadian Arctic.
Conclusions: Describing the gut microbiome of indigenous human populations will help to elucidate the impact of dietary and environmental factors on microbial community structure and identify risks linked to the lifestyles of such groups as well as endemic diseases.
Keywords: 16S rRNA sequencing; Gut microbiome; Methanobrevibacter; Microbiome-gut-brain axis; Viliuisk encephalomyelitis; Yakuts.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Epidemiology of Viliuisk encephalomyelitis in Eastern Siberia.Epidemiology. 2010 Jan;21(1):24-30. doi: 10.1097/EDE.0b013e3181c30fd2. Epidemiology. 2010. PMID: 20010208 Free PMC article.
-
Communicating hydrocephalus following eosinophilic meningitis is pathogenic for chronic Viliuisk encephalomyelitis in Northeastern Siberia.PLoS One. 2014 Feb 28;9(2):e84670. doi: 10.1371/journal.pone.0084670. eCollection 2014. PLoS One. 2014. PMID: 24586232 Free PMC article.
-
Viliuisk encephalomyelitis in Northeastern Siberia is not caused by Borrelia burgdorferi infection.Neurol Sci. 2008 Feb;29(1):11-4. doi: 10.1007/s10072-008-0852-2. Epub 2008 Apr 1. Neurol Sci. 2008. PMID: 18379734
-
The Gut Microbiome in Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS).Front Immunol. 2022 Jan 3;12:628741. doi: 10.3389/fimmu.2021.628741. eCollection 2021. Front Immunol. 2022. PMID: 35046929 Free PMC article. Review.
-
Gut microbiome research in multiple sclerosis.Neurosci Res. 2021 Jul;168:28-31. doi: 10.1016/j.neures.2021.05.001. Epub 2021 May 11. Neurosci Res. 2021. PMID: 33989681 Review.
Cited by
-
Alterations in the gut microbiota and metabolite profiles in the context of neuropathic pain.Mol Brain. 2021 Mar 9;14(1):50. doi: 10.1186/s13041-021-00765-y. Mol Brain. 2021. PMID: 33750430 Free PMC article.
-
The hallmarks of dietary intervention-resilient gut microbiome.NPJ Biofilms Microbiomes. 2022 Oct 8;8(1):77. doi: 10.1038/s41522-022-00342-8. NPJ Biofilms Microbiomes. 2022. PMID: 36209276 Free PMC article.
References
-
- L.G. Golfarb, Vladimirtsev V.A., Renwick N.M., Platonov F.A. Viliuisk encephalomyelitis. Novosibirsk: SO RAN; 2014.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical